NCT03686163View on ClinicalTrials.gov

Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2020

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Nerve Growth Factors

the experimental group patients will receive NGF 20ug/d intranasally for 2 weeks

DRUG

normal saline

The Placebo Comparator group patients will receive nomral saline 20ug/d intranasally for 2 weeks

Trial Locations (1)

210002

Department of Neurology, Jinling Hospital, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER

NCT03686163 - Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter